What’s next for GLP-1s? — Harvard Gazette
Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other…
Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other…
Newly diagnosed patients with type 2 diabetes mellitus (T2DM) should be offered a sodium–glucose co-transporter-2 (SGLT-2) inhibitor – which include dapagliflozin and empagliflozin – earlier in their treatment alongside metformin,…
When endocrinologist Mary Elizabeth Patti looks at a patient with type 2 diabetes who could benefit from weight loss, she sees more than body mass index and blood glucose levels.…
You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those…
Credit: Unsplash/CC0 Public Domain Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under…
How GLP-1s for Prediabetes Lower Blood Sugar and Aid Weight Loss | Woman’s World Use left and right arrow keys to navigate between menu items. Use escape to exit the…
Want to watch Dr. Mark Cucuzella’s full talk and hear from more experts about transforming healthcare? To unlock access to all …
in this story According to one researcher, it took just seven years for GLP-1 drugs like Ozempic to overtake insulin as the second most common treatment for type 2 diabetes.…